Lantheus Holdings, Inc. Increase (Decrease) in Income Taxes Receivable
Lantheus Holdings, Inc. (LNTH) reported Increase (Decrease) in Income Taxes Receivable of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2026-02-26
- Lantheus Holdings, Inc. increase (decrease) in income taxes receivable for the quarter ending 2024-12-31 was $0.00.
- Lantheus Holdings, Inc. increase (decrease) in income taxes receivable for the quarter ending 2024-09-30 was $0.00.
- Lantheus Holdings, Inc. increase (decrease) in income taxes receivable for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- Lantheus Holdings, Inc. increase (decrease) in income taxes receivable for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- Lantheus Holdings, Inc. increase (decrease) in income taxes receivable for fiscal 2025 was $0.00.
- Lantheus Holdings, Inc. increase (decrease) in income taxes receivable for fiscal 2024 was $0.00.
- Lantheus Holdings, Inc. increase (decrease) in income taxes receivable for fiscal 2023 was -$3.93M.
- Lantheus Holdings, Inc. increase (decrease) in income taxes receivable for fiscal 2022 was -$9.55M.
| Period end | Increase (Decrease) in Income Taxes Receivable 3 month | Increase (Decrease) in Income Taxes Receivable 6 month | Increase (Decrease) in Income Taxes Receivable 9 month | Increase (Decrease) in Income Taxes Receivable 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $0.00 10-Q · filed 2024-07-31 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | -$4.26M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-02 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | -$4.26M derived: sum of 3 quarters · filed 2026-02-26 | -$4.03M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$4.26M derived: sum of 2 quarters · filed 2026-02-26 | -$4.03M derived: sum of 3 quarters · filed 2026-02-26 | -$3.93M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$4.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$4.03M derived: sum of 2 quarters · filed 2024-11-06 | -$3.93M 10-Q · filed 2024-11-06 | -$12.81M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $231.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $327.00K 10-Q · filed 2024-07-31 | -$8.56M derived: sum of 3 quarters · filed 2025-02-26 | -$10.02M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $96.00K 10-Q · filed 2024-05-02 | -$8.79M derived: sum of 2 quarters · filed 2025-02-26 | -$10.25M derived: sum of 3 quarters · filed 2025-02-26 | -$9.85M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | -$8.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$10.35M derived: sum of 2 quarters · filed 2025-02-26 | -$9.95M derived: sum of 3 quarters · filed 2025-02-26 | -$9.55M 10-K · filed 2025-02-26 |
| 2022-09-30 | -$1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$1.06M derived: sum of 2 quarters · filed 2023-11-02 | -$668.00K 10-Q · filed 2023-11-02 | -$4.70M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $397.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $793.00K 10-Q · filed 2023-08-03 | -$3.24M derived: sum of 3 quarters · filed 2024-02-22 | -$7.06M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $396.00K 10-Q · filed 2023-05-04 | -$3.63M derived: sum of 2 quarters · filed 2024-02-22 | -$7.46M derived: sum of 3 quarters · filed 2024-02-22 | -$7.30M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | -$4.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$7.85M derived: sum of 2 quarters · filed 2024-02-22 | -$7.69M derived: sum of 3 quarters · filed 2024-02-22 | -$7.12M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$3.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$3.67M derived: sum of 2 quarters · filed 2022-11-03 | -$3.09M 10-Q · filed 2022-11-03 | -$2.54M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $158.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $731.00K 10-Q · filed 2022-08-04 | $1.28M derived: sum of 3 quarters · filed 2023-02-23 | $1.84M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $573.00K 10-Q · filed 2022-04-29 | $1.13M derived: sum of 2 quarters · filed 2023-02-23 | $1.68M derived: sum of 3 quarters · filed 2023-02-23 | $2.24M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $554.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.11M derived: sum of 2 quarters · filed 2023-02-23 | $1.66M derived: sum of 3 quarters · filed 2023-02-23 | $2.22M 10-K · filed 2023-02-23 |
| 2020-09-30 | $555.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.11M derived: sum of 2 quarters · filed 2021-11-04 | $1.66M 10-Q · filed 2021-11-04 | -$9.81M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $555.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $1.11M 10-Q · filed 2021-07-28 | -$10.37M derived: sum of 3 quarters · filed 2022-02-24 | -$11.13M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $554.00K 10-Q · filed 2021-05-04 | -$10.92M derived: sum of 2 quarters · filed 2022-02-24 | -$11.69M derived: sum of 3 quarters · filed 2022-02-24 | -$10.88M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$11.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$12.24M derived: sum of 2 quarters · filed 2022-02-24 | -$11.44M derived: sum of 3 quarters · filed 2022-02-24 | -$10.63M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$762.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $40.00K derived: sum of 2 quarters · filed 2020-11-05 | $842.00K 10-Q · filed 2020-11-05 | $1.48M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $802.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $1.60M 10-Q · filed 2020-07-31 | $2.24M derived: sum of 3 quarters · filed 2021-02-25 | $2.93M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $802.00K 10-Q · filed 2020-04-30 | $1.44M derived: sum of 2 quarters · filed 2021-02-25 | $2.13M derived: sum of 3 quarters · filed 2021-02-25 | $2.82M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $635.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.33M derived: sum of 2 quarters · filed 2021-02-25 | $2.01M derived: sum of 3 quarters · filed 2021-02-25 | $2.85M 10-K · filed 2021-02-25 |
| 2018-09-30 | $692.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $1.38M derived: sum of 2 quarters · filed 2019-10-31 | $2.22M 10-Q · filed 2019-10-31 | $9.29M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $687.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $1.53M 10-Q · filed 2019-07-25 | $8.60M derived: sum of 3 quarters · filed 2020-02-25 | $8.96M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $841.00K 10-Q · filed 2019-04-30 | $7.91M derived: sum of 2 quarters · filed 2020-02-25 | $8.27M derived: sum of 3 quarters · filed 2020-02-25 | $8.76M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $7.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $7.43M derived: sum of 2 quarters · filed 2020-02-25 | $7.92M derived: sum of 3 quarters · filed 2020-02-25 | $8.41M 10-K · filed 2020-02-25 |
| 2017-09-30 | $365.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $855.00K derived: sum of 2 quarters · filed 2018-10-30 | $1.34M 10-Q · filed 2018-10-30 | |
| 2017-06-30 | $490.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $980.00K 10-Q · filed 2018-08-01 | ||
| 2017-03-31 | $490.00K 10-Q · filed 2018-05-02 | |||
| 2016-12-31 | $200.00K 10-K · filed 2019-02-20 | |||
| 2015-12-31 | -$230.00K 10-K · filed 2018-02-26 | |||
| 2014-12-31 | -$2.72M 10-K · filed 2017-02-23 | |||
| 2013-12-31 | $566.00K 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |